Protective effects of ellagic acid in d-galactosamine-induced kidney damage in rats
- 247 Downloads
d-Galactosamine (d-GalN), which is an established experimental toxin, primarily causes liver injury by the generation of free radicals and depletion of UTP nucleotides. d-GalN intoxication also induces renal dysfunction thus, renal failure is often associated with the end-stage of the liver damage. We have investigated both preventive and curative effects of ellagic acid (EA) in this study. EA treatment at a gavage dose of 20 mg/kg body weight was administered before and after intraperitoneal (i.p.) injection of d-GalN at a dose of 750 mg/kg. Tissue and blood samples of animals were collected for morphological and biochemical evaluations. Our study results suggest that EA treatment both prior to and after the toxin administration successfully altered the toxic effects on the rats. Moreover, pre-treatment of EA was more protective than post-treatment indicated by histopathological and biochemical values. In conclusion, EA treatment both before and after d-GalN intoxication could protect kidney tissues against d-GalN induced oxidative stress.
Keywordsd-GalN Ellagic acid Apoptotic markers Renal failure
This work was supported by Anadolu University Scientific Research Project Unit (Project No: 1501F028, Ethical Committee No: 2014-22).
- Al-Kharusi N, Babiker HA, Al-Salam S, Walys MI, Nemmar A, Al-lawati I, Yasin J, Beegam S, Ali BH (2013) Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study. Eur Rev Med Pharmacol Sci 17:299–310Google Scholar
- EI-Mofty SK, Scrutton MC, Serroni A, Nicolini C, Farbar JL (1975) Early reversible plasma membrane injury in galactosamine induced liver cell death. Am J Pathol 79:579–595Google Scholar
- Keppler D, Pausch J, Decker K (1974) Selective uridine triphosphate deficiency induced by d-galactosamine in liver and reversed by pyrimidine nucleotide precursors. Effect on ribonucleic acid synthesis. J Biol Chem 249:211–216Google Scholar
- Kmiec Z, Smolenski TR, Zych M, Mysliwski A (2000) The effects of galactosamine on UTP levels in the livers of young, adult and old rats. Acta Biochim Pol 47:349–353Google Scholar
- Makin AJ, Hughes RD, Williams R, Mysliwski A (1997) Systemic and hepatic hemodynamic changes in acute liver injury. Am J Physiol 272:617–625Google Scholar
- Moore K, Taylor G, Ward P (1991) Aetiology and management of renal failure in acute liver failure. In: Williams R, Hughes RD (eds) Acute liver failure: improved understanding and better therapy. Miter Press, London, pp 47–53Google Scholar
- Quintero A, Pedraza CA, Siendones E, El-Said AMK, Colell A, Ruiz C, Montero JL, De la Mata M, Fernández-Checa JC, Miño G, Muntané J (2002) PGE1 protection against apoptosis induced by d-galactosamine is not related to the modulation of intracellular free radical production in primary culture of rat hepatocytes. Free Radic Res 36:345–355CrossRefGoogle Scholar
- Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16:360–367CrossRefGoogle Scholar
- Tolstikov GA, Baltina LA, Grankina VP, Kondratenko RM, Tolstikova TG (2007) Biodiversity, chemistry and application in medicine. Academic Publishing House, ‘Geo’ NovosibirskGoogle Scholar